This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers at the Indian Institute of Science (IISc) have found that picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses. The Institute is now looking for partners in pharmacompanies to pursue further clinical development of the findings.
Indian healthcare providers and pharmacompanies pace up their efforts with early detection and research for new medicines to combat the spread of tuberculosis as drug resistance concerns emerge. TB is a significant public health threat, with an estimated 10 million annual cases. India shares the highest TB burden with 2.69
As part of our patient advocacy efforts, at FindMeCure we are dedicated to creating a bridge between patients and the world of clinicalresearch. This includes spreading clinicaltrial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinicalresearch industry. .
COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement. Speakers at the NIHR’s recent virtual event for the pharma industry discussed best practices for bringing patient insights into research.
The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharmacompanies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.
The pharmacompanies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.
Indian pharma sees immense value in US FDA’s insistence for aluminum content and labelling recommendations for the Small Volume Parenterals Drug Products and Pharmacy Bulk Packages. Pharmacompanies in the country have increasingly made a shift to nutritional based prescription and over the counter products.
The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharmacompanies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]
The adoption of decentralised activities was a major factor in allowing clinicaltrials to continue during the early stages of the pandemic. Ben Hargreaves examines whether this adoption looks set to become a permanent feature of clinicaltrials moving into the future, rather than just supplying the tools to a temporary need.
Pharmacompanies face many challenges when involving patients in the design of clinicaltrials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Designing better trials. Involving patients in discussions.
But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinicaltrials. Pharma R&D teams are solving this problem by leveraging the power of artificial intelligence (AI) in clinicaltrials to save time and money.
Last year, the company added clinicaltrials to the list with the launch of CVS Health ClinicalTrial Services , an initiative that works with pharmacompanies on clinicaltrial recruitment and even hosts trial sites at certain retail locations. Take us back to May 2020.
The UK scientists that ran one of the largest trials of experimental COVID-19 drugs have formed a non-profit company that will apply the methodology to other disease areas – with $6.8 ” Those trials also need to be large, involve a diverse range of individuals, and able to be run at reduced cost, said Landray. .
Across the industry, pharmacompanies are turning to AI and real-world data to address many of the challenges of running clinicaltrials. David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. About the panel.
Diversity in clinicaltrials is a “scientific imperative”, but how can industry bridge the gap between “why” and “how”? Removing barriers to clinicaltrial participation for underserved groups is an essential part of addressing health inequalities. Clinicaltrial participation, she went on, was vital.
An at-home electroencephalogram (EEG) headset used alongside game-like cognitive tasks developed by UK company Cumulus Neuroscience has been shown to be more effective than lab-based EEG monitoring in a clinicaltrial. The post Cumulus’ gamified dry EEG system tops lab monitoring in trial appeared first on.
The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinicaltrial space. Hybrid or decentralised clinicaltrials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Source: Izmailova et al, 2017.
This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinicaltrials. The same principles are increasingly being applied to clinicaltrials to improve diversity, mitigate bias, and reinforce inclusion in clinicaltrials.
This is partly due to the differing business models used by pharmacompanies and digital therapeutic developers. According to Anguera, the field is in its infancy, particularly when it comes to testing approaches in clinicaltrials. Securing reimbursement for digital therapeutics also continues to impede its uptake.
The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinicaltrials, supply chain security and shortages, and environmental impact.
The competition highlights companies that demonstrated innovative solutions, technologies, and services that have the potential to make the greatest impact for biotech and pharmacompanies. The company was selected for its industry leading Virtual Care Management (VCM) program. To learn more about VirTrial, visit [link].
In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinicaltrials. In addition, 43.4 percent were using or piloting omics data.
Walmart is the latest US retail pharmacy giant to announce its intention of disrupting the clinicaltrials category, with the launch of a new institute that pledges to increase and diversify community access to healthcare research. The post Walmart follows CVS, Walgreens into clinicaltrial sector appeared first on.
Clinicaltrials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. Patient input is a crucial component of rare disease clinicaltrials, as it can provide valuable insights into the patient experience and inform decisions about study design and implementation.
At the height of the COVID-19 pandemic, these capabilities were put to the test, being used to compare hospital caseloads to research activity in real-time and enabling COVID-19 clinicaltrials to rapidly recruit participants across the UK. Why is data important?
The ‘PEP Talks’ monthly e-newsletter has approaching 50 pharmacompanies as subscribers and the inaugural ‘Patient Engagement Day’ on September 01 st achieved an inspirational number of downloads of toolkits for ways to ‘Amplify the Patient Voice’ as the launch theme. Recommendations for pharma-patient relationships.
Beyond digital clinical measures, digital solutions are maturing to address major challenges facing clinicalresearch and offer enormous promise to support the key performance indicators (KPIs) for every member of our industry. Pharmacompanies with more mature digital strategies are able to focus on questions of scale.
Ben Hargreaves discovers why medical research in the area has shifted from being highly controversial to being backed by major pharmacompanies and venture capital. The image of psychedelic drugs within medical research is changing. A psychedelic renaissance.
As pharmacompanies search for solutions to avoid cancelling or delaying clinicaltrials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. BetterLife conducts patient centric study via a fully remote clinicaltrial.
Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharmacompanies can help make patient involvement in HTA more impactful. The earlier HTAs, researchers and pharmacompanies can start that engagement the better.
A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinicaltrials submitted in support of new marketing application along with the usual structured analyses from sponsors.
deVries co-founded Medidata in 1999 as a provider of technological software solutions to advance clinicalresearch. Dassault Systèmes acquired the company in 2019 and de Vries was serving as the Life Sciences & Healthcare vice-chair for the new parent company.
ECAs are being used to support the primary approval, label expansion of their assets and even go/no-go decisions for trials. However, if history is any indication, pharmacompanies have been risk-averse when it comes to fully immersing itself into the expanded use of RWE in our development efforts.
The annual peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma highlights companies that have demonstrated innovative solutions, technologies, and services and have the potential to make the greatest impact for biotech and pharmacompanies.?. 2020 Accolades. 2018 & 2019 Achievements.
A group representing pharmacompanies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targeted drugs.
And on February 19, join An Insider’s Look: How Syneos Health is Shortening the Distance from Lab to Life in ClinicalTrials for key industry HR insights for jobseekers. The company is focused on helping develop and deliver therapeutics to patients by leading clinicaltrials globally.
There was a genuine sense of alliance; regulatory bodies and pharmacompanies coming together to accelerate processes and find the most optimal model for collaboration. Digitizing clinicaltrials. Quantifying the use of connected digital products in clinicalresearch. Published 2021 May 31. 14 Inan, O.T.,
Current regulations for preclinical research In the UK, current regulation requires that all new medicines and vaccines be tested on animal models in preclinical studies, before being tested in humans in clinicaltrials. Already, [non-animal models] are assisting greatly in the repurposing of existing drugs,” he says. “We
As this issue’s contributors discuss, by working together pharmacompanies and healthcare providers can significantly enhance oncology treatment for patients. Therapeutic cancer vaccine trials have an opportunity to leverage recent interest in vaccine technology to make headway in oncology, says Advanced Clinical’s Christopher Oelkrug.
Eversana’s expansion into real-world data (RWD) handling has gathered pace via an alliance with Thread, a specialist in decentralised clinicaltrials and electronic clinical outcome assessments (eCOAs). The post Thread, Eversana join forces on real-world data platform appeared first on.
This philosophy was behind Xperiome’s recent decision to split into two different functions – Raremark, a community where patients and carers can share their experiences of living with rare diseases, and Xperiome, which leverages those insights for pharmacompanies looking to develop drugs for these conditions.
Clinicaltrials play a pivotal role in drug development. Time is also of the essence in drug development, as competitive product-to-market lead times help pharmacompanies improve profitability. Time spent on clinicaltrials involves investment and being able to predict ADRs assists with improving the success rate.
Investigation of the possibility of VAED is crucial during clinicaltrials for decision-making on vaccine licensing by regulatory agencies. In the majority of cases, the risk of VAED is brought to light during preclinical stages or early clinicaltrial phases.
Collaboration in clinicalresearch. The last 18 months have seen some incredible scientific leaps directly tackling the pandemic, brought about by unprecedented alliances seen between pharmacompanies and between academia and pharma. As we look to the future, collaboration is key on many levels.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
189 
Let's personalize your content